Therefore, it can be reasonably speculated that the abnormal expression of BEX family genes may affect the immune cell infiltration of GBM patients, change the normal immune microenvironment, and promote the occurrence and development of GBM by affecting the signal pathway related to immune response. The gene discussed is BEX3; the disease is glioblastoma.